ARAF and colorectal carcinoma: Studies ascertaining pks+ E. coli in tumor tissue reported a lower prevalence of 22% to 55% in CRC cases.14–16 Our serological assay, however, included proteins that are not necessarily pks+ E. coli strain specific but also generally relevant for attachment to host cells, aggregation, and biofilm formation.